Interleukin-6 treatment induces beta-cell apoptosis via STAT-3-mediated nitric oxide production.
about
The involvement of interleukin-22 in the expression of pancreatic beta cell regenerative Reg genesThe pathogenic role of persistent milk signaling in mTORC1- and milk-microRNA-driven type 2 diabetes mellitusNatural history of β-cell adaptation and failure in type 2 diabetesAbnormal Glucose Metabolism in Rheumatoid ArthritisA single-nucleotide polymorphism in the interleukin-1 receptor-associated protein gene is associated with impaired glucose regulation and type 2 diabetes in a case-controlled study.Control of early Theiler's murine encephalomyelitis virus replication in macrophages by interleukin-6 occurs in conjunction with STAT1 activation and nitric oxide production.Increase of Calcium Sensing Receptor Expression Is Related to Compensatory Insulin Secretion during Aging in Mice.miR-200s contribute to interleukin-6 (IL-6)-induced insulin resistance in hepatocytes.IL-6 Promotes Islet β-Cell Dysfunction in Rat Collagen-Induced Arthritis.Compound 19e, a Novel Glucokinase Activator, Protects against Cytokine-Induced Beta-Cell Apoptosis in INS-1 Cells.Regulation of pancreatic β-cell survival by nitric oxide: clinical relevance.Differential effects of interleukin-13 and interleukin-6 on Jak/STAT signaling and cell viability in pancreatic β-cells.Fluorocarbons Enhance Intracellular Delivery of Short STAT3-sensors and Enable Specific Imaging.Do skeletal muscle-secreted factors influence the function of pancreatic beta-cells?Anakinra and tocilizumab enhance survival and function of human islets during culture: implications for clinical islet transplantation.miR-146a suppresses STAT3/VEGF pathways and reduces apoptosis through IL-6 signaling in primary human retinal microvascular endothelial cells in high glucose conditions.Cytotoxicity and Biological Efficacy of Exendin-4-Encapsulated Solid Lipid Nanoparticles in INS-1 Cells
P2860
Q21195858-92391577-F7BF-459A-91DF-80D959E86C81Q27027262-8C496B8B-2D1F-4D43-91C6-48F22D402BF4Q28082002-893AA813-DE54-4C43-B0FF-2BAEE132DE46Q33654451-182F33FA-1758-4490-A23A-C3F3322D08E4Q35803472-EDB63C1B-D0F9-4E54-AE64-6A42ADC9C862Q36276591-35CC5A1A-0233-4526-A3BC-16F36B731846Q37115445-D2D030F8-0010-46C5-B336-EB149C934F3FQ37311926-BB96B3A8-7121-4178-9498-6B1803933431Q37443601-631669DA-8BF9-4FF0-A136-EDF4C3696BBFQ37725838-6436B655-E210-488D-B845-9462B5B47E19Q38011985-F188027A-B13D-4DD4-B3FD-C5316323AA73Q39178441-E161B3BB-2450-4FB5-9059-2A97E612D9B3Q41239367-40C315A5-490E-4E8C-A23C-3511201D2E0DQ47326695-3E656363-7746-49D8-AE71-766543272268Q51026798-0392D8D1-3884-4580-A4AF-096525C23BB5Q53339809-306C6C37-A4A3-4E30-A75B-40427575A1EAQ59114025-76AD33FD-D48A-4439-9503-27F743093D0A
P2860
Interleukin-6 treatment induces beta-cell apoptosis via STAT-3-mediated nitric oxide production.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Interleukin-6 treatment induce ...... iated nitric oxide production.
@en
Interleukin-6 treatment induce ...... iated nitric oxide production.
@nl
type
label
Interleukin-6 treatment induce ...... iated nitric oxide production.
@en
Interleukin-6 treatment induce ...... iated nitric oxide production.
@nl
prefLabel
Interleukin-6 treatment induce ...... iated nitric oxide production.
@en
Interleukin-6 treatment induce ...... iated nitric oxide production.
@nl
P2093
P2860
P356
P1476
Interleukin-6 treatment induce ...... iated nitric oxide production.
@en
P2093
Eun Young Park
Hee-Sook Jun
Yoon Sin Oh
Youn-Jung Lee
P2860
P304
P356
10.1002/DMRR.1233
P577
2011-11-01T00:00:00Z